Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Akadeum Life Sciences
company
About
Akadeum is working to fundamentally change the way that cell sorting is performed and thought about.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $17.50M
- Industries
- Biotechnology,Information Technology,Medical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Akadeum Life Sciences is working on the problem of isolating mammalian and bacterial cells from complex mixtures. It creates the simplest bioseparation products and fundamentally change the way that isolating cells and other biological targets approached. The company currently uses microbubbles for applications in cell separation and other related areas.Akadeum Life Sciences was founded in 2014 and is headquartered in Ann Arbor, Michigan, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$19M
Akadeum Life Sciences has raised a total of
$19M
in funding over 2 rounds. Their latest funding was raised on
Oct 12, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 12, 2021 | Series B | $17.50M | 2 | — | — | Detail |
| Dec 19, 2019 | Series A | — | 1 |
|
— | Detail |
| Sep 6, 2017 | Series Unknown | $1.50M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Akadeum Life Sciences is funded by 3 investors.
BioInfleXion Point Partners
and Agilent Technologies
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series Unknown |
Agilent Technologies
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
